Radiesse®Find A DoctorRADIESSE Cosmetic

To view more before and after cases, click here.

The Advantages of Radiesse® Dermal Filler

RADIESSE filler is ideal for the correction of HIV-associated Facial Lipoatrophy and offers significant advantages over alternative fillers.

RADIESSE treatment provides the following advantages:

RADIESSE Filler - Safety

RADIESSE filler is biocompatible, nontoxic, and nonantigenic, and contains calcium hydroxylapatite (CaHA) that has been used safely for decades in a vast spectrum of clinical applications − from orthopedics to dentistry − with no device related significant adverse events reported in our FDA clinical study.

To establish the safety and longevity of RADIESSE treatments, BioForm Medical has conducted clinical trials in Europe and North America and collected more clinical data than is available for any other dermal filler product. Through extensive clinical use published in peer-reviewed journals, RADIESSE dermal filler treatments have proven to be safe and effective, and may last a year or more in many patients, results may vary. For more information, please review these clinical results and peer-review articles.

RADIESSE Filler Physician Testimonials

"Our clinical experience validates the long-lasting benefits of RADIESSE to achieve dramatic improvements in the appearance of facial wasting. This correction, which generally lasts well over one year, favorably impacts these patients' quality of life without subjecting them to an invasive procedure. In addition, patients can return to normal activities almost immediately looking healthy and confident." - Dr. Joseph A. Eviatar, Ophthalmic Plastic and Reconstructive Surgeon, Chelsea Eye & Cosmetic Surgery Associates, New York, NY.

"One of the top concerns among patients with HIV is that their treatment regimen can leave them with a gaunt look which is a telltale sign of the condition. The FDA's approval of RADIESSE for correction of the signs of Facial Lipoatrophy in HIV patients is a giant step forward for the countless men and women seeking a safe, non-surgical approach to restore their appearance. With results that last a year or more in many patients, and with typically fewer office visits required to achieve optimal patient outcomes, RADIESSE lessens the burden on patients and makes a huge difference in their overall quality of life." - Dr. Michael I. Echavez, Facial Plastic Surgeon, Private Practice, San Francisco, CA.

"In our clinical experience, RADIESSE is aiming to become the new standard of treatment for HIV-associated Facial Lipoatrophy because we can successfully treat the signs of facial fat loss and restore a natural, healthy look. For our HIV patients, RADIESSE provides the important advantages of safety, convenience, and value while delivering long-lasting, effective results." - Dr. Stacey L. Silvers, Principal Physician in the New York Otolaryngology Group, Facial Plastic Surgery & Cosmetic Center, New York City Facial Plastic Surgery in New York, NY.

"As a primary care physician, it's important to bring quality care closer to patients, especially those with HIV who desire the most advanced yet affordable treatment. With RADIESSE, we canprovide a next generation filler that is simple to administer, keeps patients looking healthy for the long term and offers versatility in correcting the signs of facial fat loss. I expect RADIESSE to make a huge positive change in my practice." - Dr. John D. Stansell, Clinical Professor of Medicine, UCSF, Private Practice, Palm Springs, CA.

back to top